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A B S T R A C T
Objective: First degree relatives (FDRs) of someone with colorectal cancer (CRC) are at increased risk of
the disease. In this study we examine the factors associated with discussing family history of CRC with a
health professional.
Methods: People with CRC, recruited through the population-based Victorian Cancer Registry in
Australia, were asked to refer FDRs to the study. Eight hundred and nineteen FDRs completed a telephone
interview.
Results: Thirty-six percent of FDRs recalled ever being asked about their family history of bowel cancer
by a health professional. Factors associated with having this discussion were being aged 50–60 years,
having a university education, being in the potentially high risk category, being very worried about
getting bowel cancer and knowing that family history increases risk through discussions with family,
friends or their own education.
Conclusion: Despite evidence that doctor endorsement is a key factor in the uptake of CRC screening, our
study shows that the majority of FDRs do not recall being asked by a health professional about their
family history.
Practice implications: There is a need to identify the most appropriate method to improve rates of health
professional discussion of family history with relatives of CRC patients in order to improve screening
rates.
 2013 The Authors. Published by Elsevier Ireland Ltd.  
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Colorectal cancer (CRC) is the fourth leading cause of cancer
related death worldwide [1]. Australia has one of the highest
incidence with 1 in 22 people developing the disease by the age of
75 [2]. Those diagnosed at an early stage have a 5 year survival rate
of 90%, compared with 10% for those with advanced metastatic
disease [3]. Despite this, less than 20% of CRCs in Australia are
detected at the earliest stage of the disease [4].
The risk of developing CRC increases sharply over the age of 50
and among relatives of those with CRC [5]. Based on the number of
affected relatives and the presence of high risk features, Australian
guidelines classify ﬁrst degree relatives (FDRs) as at average/* Corresponding author at: Priority Research Centre for Health Behaviour, School
of Medicine & Public Health, W4, HMRI Building, University of Newcastle,
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Open access under CC Bslightly above average risk, moderate risk, and potentially high
risk. Different screening regimens are recommended for those in
each risk category. Despite their higher risk, our data indicate that
adherence to screening recommendations is only 39% among FDRs
of people with CRC [6].
Adherence to screening guidelines requires that FDRs are aware
of their level of risk, and the corresponding screening recommen-
dations. There is no systematic mechanism for providing
information about CRC risk for family members of those diagnosed
with the disease. Therefore, it often falls to general practitioners
(GPs) to assess risk and provide screening recommendations as
part of preventive care. Our recent data indicate that being asked
by a health professional about their family history of CRC was a
signiﬁcant predictor of being screened in accordance to guidelines
among FDRs [6]. However, there is limited evidence that this does
not routinely occur in clinical practice. In a survey of community
dwelling Australians aged over 50, 38% reported ever being asked
about their family history of CRC by a health professional [7]. A
study in North America of patients with CRC who had a ﬁrst or
second degree relative affected reported 59% having a family
history documented [8]. An audit of medical records in a North
American family practice found 55% recorded a family history ofY-NC-SA license.
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UK hospital involving patients diagnosed with CRC under age 60
found 54% of case notes referenced family history of cancer and
20% included the age of diagnosis of family members [10].
In this study we examine the factors that are associated with
discussing family history of CRC with a health professional. Prior
research has shown that a recent family cancer event is most
commonly the motivator for a FDR to visit their GP [11,12], with
level of education also predictive in inﬂuencing health mainte-
nance visits [13].
The aim of the current project was to: (1) describe the
proportion of FDRs who report discussing family history of CRC
with a health professional; (2) how and when they became aware
of family history as a risk factor; and (3) identify whether older age,
female gender, country of birth, education, greater family risk
status, worry about getting bowel cancer, or how became aware of
increased risk is associated with greater likelihood of having
discussed family risk with a health professionals.
2. Methods
2.1. Eligibility
FDRs of people with CRC were eligible to participate in the trial
if they were: (1) aged 18 or older; (2) English speaking; (3) able to
provide informed consent; and (4) did not have a prior diagnosis of
CRC, advanced adenoma, familial adenomatous polyposis (FAP), or
Crohn’s disease, ulcerative colitis, or other inﬂammatory bowel
disease.
2.2. Recruitment
Data for this study were collected between February 2010 and
November 2012. CRC patients were identiﬁed by the cancer
registry and invited to participate in the trial if they were over 18,
within ten months of diagnosis, English speaking and able to
provide informed consent and considered able to participate by
their clinician [14]. Consenting patients completed a baseline
computer-assisted telephone interview (CATI) which asked about:
(1) family history of CRC, high risk related cancers, high risk genes
and FAP; and (2) total number of living FDRs over the age of 18, and
whether the research team could contact them to invite the FDRs
to participate. Information collected from the CRC patients was
used to classify the family risk status of their FDRs according to a
modiﬁed version of the National Health and Medical Research
Council’s risk categories [15]:
Category 1. At or slightly above average risk: Index cases (ICs)
with no ﬁrst or second degree relatives diagnosed with bowel
cancer and who were diagnosed themselves over age 55.
Category 2. Moderately increased risk: ICs diagnosed before the
age of 55 without other high risk factors and those with 1 or 2
ﬁrst or second degree relatives not on the same side of the
family diagnosed with bowel cancer without any high risk
features.
Category 3. Potentially high risk: ICs diagnosed under the age of
55 with multiple bowel cancer or 2 or more ﬁrst or second
degree relatives on the same side of the family diagnosed with
bowel cancer, or a ﬁrst or second degree relative with any high
risk features. High risk features include multiple bowel cancers
in one person; bowel cancer diagnosed before the age of 50; a
relative with cancer of the endometrium, ovary, stomach, small
bowel, renal pelvis, ureter, biliary tract or brain; a FDR with FAP;
or a relative with a high risk gene identiﬁed through genetic
testing.FDRs that consented participated in a brief screening interview
to assess trial eligibility. Those with a prior diagnosis of CRC,
advanced adenoma or FAP, or Crohn’s disease, ulcerative colitis, or
other inﬂammatory bowel disease were considered ineligible.
2.3. Measures
Eligible FDRs completed a baseline CATI comprising a series of
modules a subset of which are reported here.
Socio-demographic questions: Items included age, gender,
country of birth, postcode, marital status, level of education,
employment status and whether they have private health cover.
The relationship between the FDR and the IC was known from the
IC interview.
Awareness of family risk: FDRs were asked when they ﬁrst
became aware that having a family history of bowel cancer
increases a person’s risk of developing bowel cancer (‘‘less than a
month ago’’; ‘‘1 month to less than 12 months ago’’; ‘‘12 months to
less than 2 years ago’’; ‘‘2 years to less than 5 years ago, 5 years or
longer’’; ‘‘Don’t know that family history increases risk’’), and were
asked what ﬁrst alerted them to this fact (‘‘The letter I received
from the Cancer Council’’; ‘‘A member of my family was diagnosed
with bowel cancer’’; ‘‘Information from the TV, radio or newspa-
per’’; ‘‘My doctor discussed the risk of bowel cancer with me’’;
‘‘Other’’; ‘‘Don’t know/Not sure’’).
Discussions with health professional: FDRs were asked whether a
health professional had ever asked about their family history of
bowel cancer, the type of health professional who asked (‘‘GP’’,
‘‘cancer specialist’’, ‘‘genetic counsellor’’ or ‘‘other’’), how long ago
they were asked (‘‘less than a month ago’’; ‘‘1 month to less than 12
months ago’’; ‘‘12 months to less than 2 years ago’’; ‘‘2 years to less
than 5 years ago, 5 years or longer’’; ‘‘Don’t know/ Not sure’’) and
how many times they have consulted that health professional
about family history or bowel cancer or screening for bowel cancer.
2.4. Data analysis
All analyses were conducted in Stata 11.2. Responses to the
survey questions were tallied and divided by the total number of
participants to calculate proportions, taking the response ‘‘Not
sure’’ as a negative response. The characteristics of FDRs associated
with having discussed their family history of CRC with a health
professional were assessed using logistic regression modelling in a
generalized estimation equation framework to account for
multiple FDRs per family. The variables age, gender, Australian
born, education, family risk category, level of worry and how they
became aware that a family history increased risk were entered
into the model. Those who knew that a family history increased
risk due to discussions with a doctor were excluded from the
regression analysis.
2.5. Ethical approval
This study was approved by the University of Newcastle (2008-
0047) and Cancer Council Victoria (0810) ethics committee, and all
participants provided written consent.
3. Results
Of the 2928 eligible ICs sent a letter by the registry, 1084 (37%)
gave consent for their details to be given to the research team and
753 (69%) completed the baseline interview. Of these, 649 (86%)
had FDRs and agreed to them being invited to participate in the
study. This led to 2376 FDRs being sent an invitation letter and 904
(38%) consenting to complete the interview to assess trial
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(X2(1) = 34.0, p < 0.001) compared with FDRs who were sent the
invitation letter but did not consent to the study. There was no
difference in consent rate depending on family risk status and
relationship to the IC (Carey et al., unpublished). Forty consenting
FDRs were ineligible to participate and 819 completed the baseline
interview. These FDRs belonged to 416 families with an average of
1.91 members (SD = 1.13) per family. The demographics of the FDR
participants are shown in Table 1.
3.1. Discussions with health professional
Overall 36% (295/819) of participants recalled ever being asked
about their family history of bowel cancer by a health professional.
Most discussions about family history of bowel cancer were with a
GP (84%) while 20% involved a cancer specialist, 1.4% a genetic
counsellor and 4.4% another sort of medical professional. Most of
the discussions took place in the past 12 months (69%). However,
16% were over 5 years ago. On average FDRs who have discussed
family history with a health professional have done so on 2.34
occasions (SD = 2.18).
3.2. Awareness of family risk
Just under half the sample reported that they had known that
family history increases risk of bowel cancer for longer than 5 years
(46%) while 43% became aware in the past year. The length of time
that participants knew this fact was dependent on how they knew
(Table 2; X2(3df) = 308, p < 0.001). Those who found out after a
family member was diagnosed (62%) or from the letter sent by the
Cancer Council (3%) were more likely to have found out recently
compared to those who knew from information obtained from the
media (18%), discussions with their doctor (3%), from their own
education (10%) or talking with friends and relatives (4%).Table 1
Characteristics of FDRs included in the study (N = 819).
N (%)
Age, mean (SD) 51 years (14)
Under 40 years 168 (21%)
40–49 214 (26%)
50–59 215 (26%)
60–69 130 (16%)
Over 70 years 92 (11%)
Male 334 (41%)
Australian born 752 (92%)
Live in urban area 471 (58%)
Married/Defacto 636 (78%)
Education
University degree 354 (43%)
Vocational training 177 (22%)
Completed high school 107 (13%)
Did not complete high school 181 (22%)
Employment
Full or part time work 569 (74%)
Retired 138 (18%)
Not working 62 (8%)
Private health cover 576 (70%)
Family risk status
At or slightly above average 443 (54%)
Moderately increased 131 (16%)
Potentially high 245 (30%)
Relationship to patient
Parent 30 (3.7%)
Sibling 287 (35%)
Child 502 (61%)
Level of worry about getting bowel cancer
Not at all worried 314 (38%)
Slightly worried 360 (44%)
Very worried 145 (18%)The results of the multiple logistic regression modelling are
presented in Table 3. The factors associated with being asked by a
health professional about family history of bowel cancer are: aged
50–60 compared to under 50, having a university education, being
in the potentially high risk category, being very worried about
getting bowel cancer and knowing that family history increases
risk through discussions with family, friends or their own
education. Gender and whether participants were born in Australia
did not inﬂuence whether a health professional had discussed
family history.
4. Discussion and conclusion
4.1. Discussion
Despite having a FDR diagnosed with bowel cancer only 36% of
participants reported being asked about family history of CRC by a
health professional. These results are in line with a recent study by
Courtney et al. [7] of community-dwelling adults aged 50 and
older, which found that 38% had been asked about family history
by a health professional. Previous research has shown that doctor
endorsement is a key factor in promoting screening participation
[12,16,17]. Therefore, the low rates of recall of doctor discussion
identiﬁed in this study are of concern.
Those aged 50–60 were more likely than younger participants
to have discussed family history with their doctor. This may reﬂect
that current screening guidelines recommend population screen-
ing for CRC commence at age 50. Therefore, some participants in
this age group should have been contacted by the National Bowel
Cancer Screening Program and may have discussed the invitation
with their doctor, or may have had their doctor proactively initiate
discussion of CRC screening given that they are at the appropriate
age for screening.
Those at highest risk of CRC were also more likely than other
respondents to have had a discussion about family history. A study
by Honda and Neugut [18] demonstrated that perceived risk may
be a dose-response relationship, i.e., the greater number of family
members affected, the greater the perceived risk. Therefore it is
likely that those at highest risk who may have several relatives
affected by CRC are more aware of their risk, and have potentially
been exposed to triggers to discuss this with a health professional.
As found in other studies [13] level of education was also
associated with discussing family cancer history with a doctor.
Over half of the participants knew about increased risk
associated with family history due to a family member being
diagnosed with CRC. This is similar to the ﬁndings of Lim et al. [12]
that family cancer events and reaching the age at which relatives
were diagnosed with cancer had a bigger impact in raising the
awareness of the risk due to family history than the media and
publicity. This is likely due to the feelings of personal susceptibility
that a family cancer event may evoke. Nevertheless, media
campaigns have been shown to be effective in increasing
awareness of and promoting uptake of health behaviours in
relation to some screening behaviours [19,20], and hence, the
potential role of the media in relation to awareness of the risks
conferred by family history of CRC should be further explored.
4.1.1. Limitations
One of the strengths of the current study was the attempt to
gain a population perspective by contacting all eligible ICs
identiﬁed through a population-based cancer registry, and
subsequently contacting the FDRs of consenting ICs. The consent
rate for ICs and FDRs in the current study was low, however, raising
concerns about generalizability of the results. While we were
unable to collect data on these characteristics, it is possible that
non-consenters were less health conscious and had lower health
Table 2
How long FDRs have known that family history of bowel cancer increases the risk of developing bowel cancer by how they know (N = 804).
Know because a family
member was diagnosed
Know through
the media
Know through talking
with doctor
Know through family or
friends or own education
Total
N (%) N (%) N (%) N (%) N (%)
Known for less than 2 years 371 (71%) 10 (7%) 7 (39%) 2 (2%) 390 (49%)
Known for longer than 2 years 153 (29%) 136 (93%) 11 (61%) 114 (98%) 414 (51%)
Total 524 (65%) 146 (18%) 18 (3%) 116 (14%) 804
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of the proportion who recalled discussing family history of CRC
with their doctor.
It is possible that recall biases may have affected participants’
ability to accurately recall the timing of discussions with health
professionals. However, bounded recall techniques including cues
such as diagnosis of a family member, or receipt of the letter from
the Cancer Council about the study were used, and may have
facilitated recall.
4.2. Conclusion
Our data indicate that despite the evidence that doctor
endorsement is a key factor in the uptake of CRC screening, the
majority of FDRs of people with CRC do not recall being asked by a
health professional about their family history. While other studies
have identiﬁed this as a potential gap, ours is the ﬁrst to do so in a
population-based sample of FDRs of people with CRC. This suggests
that even those who are at higher risk of CRC (i.e. those with an FDR
with CRC) are unlikely to recall having discussed this risk factor
with a health professional. There is a need to identify the most
appropriate method of providing FDRs information about potential
risks of developing CRC that is tailored to their level of risk.Table 3
Multiple logistic regression model of factors associated with having discussed family h
Asked about family hist
N (%) 
Age categories
Under 40 years 53 (32%) 
40–50 years 68 (33%) 
50–60 yearsa 89 (43%) 
60–70 years 42 (34%) 
Over 70 years 25 (30%) 
Gender
Malea 114 (36%) 
Female 163 (35%) 
Australian born
Noa 25 (38%) 
Yes 252 (35%) 
Education
University degreea 139 (41%) 
Vocational training 54 (31%) 
Completed high school 29 (28%) 
Did not complete high school 55 (31%) 
Family risk category
At or above average riska 137 (32%) 
Moderately increased risk 44 (34%) 
Potentially high risk 96 (41%) 
Level of worry about getting bowel cancer
Not at all worrieda 95 (32%) 
Slightly worried 123 (36%) 
Very worried 59 (42%) 
How know that family history increases risk
Family member diagnosed 173 (33%) 
Media 48 (33%) 
Family, friends or own education 56 (48%) 
Total 277 (35%)
a Reference category.4.3. Practice implications
Given that there were many cases where discussion of family
history did not occur following a family member’s diagnosis, the
development of systems to prompt initiation of this in primary care
is warranted. Other approaches using the IC diagnosis as the
catalyst for providing screening information to FDRs through
cancer registries [14,21], and through cancer treatment centres
[22] should be investigated. Despite inﬂuence of primary care
physicians being commonly acknowledged as a strong indicator for
screening behaviour, advice from surgeons and other cancer
specialists may also be considered as an appropriate strategy to
reach FDRs through patients and encourage consultation with their
GP regarding CRC risk [23,24].
Results indicate that strategies designed to promote discussion
of family risk and screening recommendations for CRC need to be
appropriate in reaching subgroups who were less likely to recall
having had such discussions in the past: those with less education,
those who are less worried about developing CRC, and those with
lower risk of CRC. For example, strategies may need to emphasise
the need to discuss CRC risk even if you only have one affected
relative, or alternatively GPs could adopt an opportunistic
approach whereby screening recommendations are provided toistory of bowel cancer with a health professional (N = 786).
ory Odds ratio p value
(95% CI)
0.56 (0.35–0.89) 0.013
0.62 (0.41–0.94) 0.026
Ref Ref
0.68 (0.42–1.1) 0.113
0.6 (0.34–1.08) 0.087
Ref Ref
0.86 (0.63–1.17) 0.335
Ref Ref
0.91 (0.52–1.58) 0.736
Ref Ref
0.62 (0.41–0.92) 0.019
0.57 (0.35–0.93) 0.023
0.66 (0.43–1.01) 0.057
Ref Ref
1.11 (0.7–1.75) 0.663
1.55 (1.08–2.23) 0.018
Ref Ref
1.2 (0.85–1.7) 0.288
1.67 (1.07–2.6) 0.025
Ref Ref
0.98 (0.66–1.46) 0.927
1.76 (1.15–2.71) 0.009
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increase perceptions of vulnerability also need to include
information about the potential to reduce risk through screening
participation and need to be presented in a way that is accessible
and easy to understand for a broad demographic [26,27].
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